News and features
Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
Radiotherapy boost cuts breast cancer treatment time by at least one week
Treatment times for radiotherapy could be reduced for some early breast cancer patients, according to the IMPORT HIGH trial.
Animal kingdom-wide AI tool could help unravel cancer complexity
An international study led by ICR scientists has accurately categorised tumour and immune cells of non-human animal species by applying an artificial intelligence (AI) algorithm that was trained on human lung cancer samples.
Next-generation trial shows five-drug combo can keep ‘ultra-high-risk’ bone marrow cancer at bay
Combining five existing drugs can keep a highly aggressive type of bone marrow cancer at bay for longer, an innovative trial has shown.
Untapping the full potential of immunotherapies for more people with cancer
Immunotherapy works by sparking the body’s own immune system into action against tumours. It has become a first-choice treatment for some types of cancer, and now there are exciting opportunities to unlock its benefits for more patients through research. Jane Shepley explores the story behind immunotherapy and how we can untap its potential.
ASCO 2023: New drug combination twice as effective for some ovarian cancer patients as next best treatment
A targeted drug combination for patients with a type of ovarian cancer could be nearly twice as effective as the next best treatment, according to interim results from a phase II study.
Detailed structure of understudied cell division ‘nanomachine’ revealed
Researchers have revealed, at high-resolution, the structure of a human protein complex named SIN3B, which is a ‘nanomachine’ involved in regulating cell division – a fundamental process for life which, if it becomes uncontrolled, can lead to cancer.
Major study reveals how pancreatic cancer changes its ‘diet’ to survive
Pancreatic cancer cells can change their ‘diet’ to keep growing, by switching from the sugar glucose to a back-up fuel called uridine, new research reveals.
England’s first Integrated Pathology Unit focusing on clinical trial research will use novel technology to diagnose cancer faster and more affordably
England’s first centre of its kind is set to make significant improvements in cancer diagnosis and treatment – by combining pioneering digital imaging with artificial intelligence.
Cell ‘nanobot’ breakthrough shines light on cause of aggressive cancers
Scientists have uncovered the inner workings of one of the most important and intricate ‘nanobots’ operating within our cells – using cutting-edge microscopy for visualising molecules almost at an atomic level. Their new study published in Nature has unveiled the critical step that switches on the spliceosome – a piece of cellular machinery that enables cells to build complex proteins.
ICR’s Chief Executive elected as Foreign Member of the Royal Society
Professor Kristian Helin, a world-leading cancer researcher and Chief Executive of The Institute of Cancer Research, London, has been elected as a Foreign Member of the Royal Society in recognition of his outstanding contribution to cancer research.
ICR-discovered drug to enter phase II clinical trial in ovarian cancer thanks to new research collaboration
An innovative cancer drug discovered by scientists at The Institute of Cancer Research, London, is set to enter a new clinical trial.
AI could help doctors diagnose lung cancer
Artificial intelligence (AI) could help doctors diagnose lung cancer earlier, according to a study led by researchers from The Royal Marsden NHS Foundation Trust in collaboration with The Institute of Cancer Research, London, and Imperial College London.
